How and When Do Myocytes Die During Ischemia and Reperfusion: The Late Phase
- 1 September 2011
- journal article
- review article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 16 (3-4), 239-243
- https://doi.org/10.1177/1074248411407769
Abstract
While the majority of the cardiac myocyte death that makes up the final infarct occurs during ischemia and the first few minutes of reperfusion, cell death does not stop there. In fact necrosis and apoptosis, and potentially autophagy, can continue in the previously ischemic area for up to 3 days post-reperfusion. Several mechanisms can potentially contribute to this death continuum: (1) myocytes that have already passed the point of no return despite reperfusion; (2) continued dysfunction of the coronary microvasculature; and (3) infiltration of inflammatory cells. The latter in particular leads to elevated myocardial concentrations of reactive oxygen species (ROS), inflammatory cytokines, activation of toll-like receptors, secretion of toxic enzymes, and activation of the complement cascade—all of which can lead to myocyte death. However, there is a considerable lack of studies that comprehensively examine the time course, nature, and mechanisms of post-reperfusion myocyte death. Moreover, cell death types (apoptosis, necrosis, and autophagy) are inextricably linked to one another. Therefore, we do not know whether specific blockade of necrosis during the acute phase of myocyte death will instead enhance apoptosis during the late phase, that is, will we be simply delaying the inevitable? Consequently, the purpose of this article is to briefly review what we do, and more importantly what we do not, know about cardiac cell death in the reperfused heart and what is needed to advance our understanding of this phenomenon.Keywords
This publication has 27 references indexed in Scilit:
- Oxidative Stress Stimulates Autophagic Flux During Ischemia/ReperfusionAntioxidants and Redox Signaling, 2011
- Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRIAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in miceJCI Insight, 2007
- Distinct Roles of Autophagy in the Heart During Ischemia and ReperfusionCirculation Research, 2007
- The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusionBasic Research in Cardiology, 2006
- Reduction of infarct size and preservation of endothelial function by multidose intravenous adenosine during extended reperfusionJournal of Surgical Research, 2004
- Progressively developed myocardial apoptotic cell death during late phase of reperfusionApoptosis, 2001
- Dynamic Progression of Contractile and Endothelial Dysfunction and Infarct Extension in the Late Phase of ReperfusionJournal of Surgical Research, 2000
- Reperfusion induces myocardial apoptotic cell deathCardiovascular Research, 2000
- Time course of coronary endothelial healing after injury due to ischemia and reperfusion.Circulation, 1994